<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136204">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01953380</url>
  </required_header>
  <id_info>
    <org_study_id>ISICA-13</org_study_id>
    <nct_id>NCT01953380</nct_id>
  </id_info>
  <brief_title>Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy</brief_title>
  <acronym>ISICA-13</acronym>
  <official_title>Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether extended information given to patients
      with contact allergy improves knowledge, treatment efficacy and daily functioning.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>knowledge</measure>
    <time_frame>one year after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical improvement</measure>
    <time_frame>one year after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>one year after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed by questionnaire, Dermatology Life Quality Index (DLQI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effect on daily functioning</measure>
    <time_frame>one year after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Dermatitis, Allergic Contact</condition>
  <arm_group>
    <arm_group_label>extended information</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extended information on specific allergy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information according to clin. routine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Information according to clinical routine</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>extended information</intervention_name>
    <arm_group_label>extended information</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected contact allergy

          -  Age above 18 years

          -  Participants have given informed consent

        Exclusion Criteria:

          -  Mental or language disabilities
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Sonesson, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne, Hudkliniken SUS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Sonesson, MD PhD</last_name>
    <phone>+4646171134</phone>
    <email>andreas.sonesson@med.lu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>William Troensegaard, MD</last_name>
    <phone>+4646171134</phone>
    <email>william.troensegaard@skane.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hudmottagningen SUS</name>
      <address>
        <city>Lund</city>
        <state>Skåne</state>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>William Troensegaard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 14, 2014</lastchanged_date>
  <firstreceived_date>September 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Andreas Sonesson</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Intervention Studies</keyword>
  <keyword>Eczema</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Knowledge</keyword>
  <keyword>Quality of Life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Allergic Contact</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
